Pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis;Maladie veino-occlusive et hémangiomatose capillaire pulmonaire

Presse Medicale

Volumn 39, Issue 1, 2010, Pages 134-143

  Montani, David ^a,b,c   Dorfmuller, Peter ^a,b,c   Maitre, Sophie ^a   Jaïs, Xavier ^a,b,c   Sitbon, Olivier ^a,b,c   Simonneau, Gérald ^a,b,c   Humbert, Marc ^a,b,c  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c Universite Paris Sud   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; CORTICOSTEROID; ENDOTHELIN RECEPTOR ANTAGONIST; OXYGEN; PHOSPHODIESTERASE V INHIBITOR; PROSTACYCLIN; RECOMBINANT ALPHA2A INTERFERON; SILDENAFIL; WARFARIN;

BLOOD GAS ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; DISEASE SEVERITY; EUROPE; HISTOPATHOLOGY; HUMAN; LUNG BIOPSY; LUNG CAPILLARY; LUNG DIFFUSION; LUNG EDEMA; LUNG FUNCTION TEST; LUNG LAVAGE; LUNG TRANSPLANTATION; MEDICAL DECISION MAKING; MEDICAL SOCIETY; OXYGEN THERAPY; PATIENT CARE; PRACTICE GUIDELINE; PREVALENCE; PROGNOSIS; PULMONARY CAPILLARY HEMANGIOMATOSIS; PULMONARY HYPERTENSION; PULMONARY VEIN; PULMONARY VENO-OCCLUSIVE DISEASE; SHORT SURVEY;

BRONCHOALVEOLAR LAVAGE; CAPILLARIES; HEMANGIOMA; HUMANS; HYPERTENSION, PULMONARY; LUNG NEOPLASMS; PROGNOSIS; PULMONARY VEINS; PULMONARY VENO-OCCLUSIVE DISEASE; RESPIRATORY FUNCTION TESTS; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 73749084784     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2009.09.013     Document Type: Short Survey

References (38)

1. Simonneau G., Robbins I.M., Beghetti M., Channick R.N., Delcroix M., Denton C.P., et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 54 (2009) S43-54
2. Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. The task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Respir J 2009; 0: 09031936.00139009v2.
3. Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009; 30:2493-537.
4. Montani D, O'Callaghan D, Jaïs X, Savale L, Natali D, Redzepi A et al.. Implementing the ESC/ERS pulmonary hypertension guidelines: real-life cases from a national referral centre. Eur Respir Rev 2009; 18: 114, 231-249.
5. Dorfmuller P., Humbert M., Perros F., Sanchez O., Simonneau G., Müller K.M., et al. Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases. Hum Pathol 38 (2007) 893-902
6. Rabiller A., Jais X., Hamid A., Resten A., Parent F., Haque R., et al. Occult alveolar haemorrhage in pulmonary veno-occlusive disease. Eur Respir J 27 (2006) 108-113
7. Resten A., Maitre S., Humbert M., Rabiller A., Sitbon O., Capron F., et al. Pulmonary hypertension: CT of the chest in pulmonary venoocclusive disease. AJR Am J Roentgenol 183 (2004) 65-70
8. Rambihar V.S., Fallen E.L., and Cairns J.A. Pulmonary veno-occlusive disease:antemortem diagnosis from roentgenographic and hemodynamic findings. Can Med Assoc J 120 (1979) 1519-1522
9. Montani D., Achouh L., Dorfmuller P., Le Pavec J., Sztrymf B., Tchérakian C., et al. Pulmonary veno-occlusive disease: clinical, functional, radiologic, and hemodynamic characteristics and outcome of 24 cases confirmed by histology. Medicine (Baltimore) 87 (2008) 220-233
10. Montani D., Price L.C., Dorfmuller P., Achouh L., Jaïs X., Yaïci A., et al. Pulmonary veno-occlusive disease. Eur Respir J 33 (2009) 189-200
11. Pietra G.G., Capron F., Stewart S., Leone O., Humbert M., Robbins I.M., et al. Pathologic assessment of vasculopathies in pulmonary hypertension. J Am Coll Cardiol 43 (2004) 25S-32S
12. Lantuejoul S., Sheppard M.N., Corrin B., Burke M.M., and Nicholson A.G. Pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis: : a clinicopathologic study of 35 cases. Am J Surg Pathol 30 (2006) 850-857
13. Holcomb Jr. B.W., Loyd J.E., Ely E.W., Johnson J., and Robbins I.M. Pulmonary veno-occlusive disease: : a case series and new observations. Chest 118 (2000) 1671-1679
14. Mandel J., Mark E.J., and Hales C.A. Pulmonary veno-occlusive disease. Am J Respir Crit Care Med 162 (2000) 1964-1973
15. Souza R., Humbert M., Sztrymf B., Jaïs X., Yaïci A., Le Pavec J., et al. Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases. Eur Respir J 31 (2008) 343-348
16. Montani D, Jais X, Price LC, Achouh L, Degano B, Mercier O et al. Cautious epoprostenol therapy is a safe bridge to lung transplantation in pulmonary veno-occlusive disease. Eur Respir J 2009; 34: doi:10.1183/09031936.00017809.
17. Nunes H., Humbert M., Capron F., Brauner M., Sitbon O., Battesti J.P., et al. Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis. Thorax 61 (2006) 68-74
18. Fartoukh M., Humbert M., Capron F., Maître S., Parent F., Le Gall C., et al. Severe pulmonary hypertension in histiocytosis X. Am J Respir Crit Care Med 161 (2000) 216-223
19. Runo J.R., Vnencak-Jones C.L., Prince M., Loyd J.E., Wheeler L., Robbins I.M., et al. Pulmonary veno-occlusive disease caused by an inherited mutation in bone morphogenetic protein receptor II. Am J Respir Crit Care Med 167 (2003) 889-894
20. Aldred M.A., Vijayakrishnan J., James V., Soubrier F., Gomez-Sanchez M.A., Martensson G., et al. BMPR2 gene rearrangements account for a significant proportion of mutations in familial and idiopathic pulmonary arterial hypertension. Hum Mutat 27 (2006) 212-213
21. Machado R.D., Aldred M.A., James V., Harrison R.E., Patel B., Schwalbe E.C., et al. Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension. Hum Mutat 27 (2006) 121-132
22. Montani D., Kemp K., Dorfmüller P., Sitbon O., Simonneau G., and Humbert M. Idiopathic Pulmonary Arterial Hypertension and Pulmonary Veno-occlusive Disease: Similarities and Differences. Semin Respir Crit Care Med 30 (2009) 411-420
23. Sitbon O., Humbert M., Jais X., Ioos V., Hamid A.M., Provencher S., et al. Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension. Circulation 111 (2005) 3105-3111
24. Humbert M., Sitbon O., and Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med 351 (2004) 1425-1436
25. Montani D, Achouh L, Sitbon O, Simonneau G, Humbert M. Pulmonary venoocclusive disease and failure of specific therapy. Chest 2009;136:1181.
26. Wagenvoort C.A., and Wagenvoort N. The pathology of pulmonary veno-occlusive disease. Virchows Arch A Pathol Anat Histol 364 (1974) 69-79
27. Chazova I., Robbins I., Loyd J., Newman J., Tapson V., Zhdaov V., et al. Venous and arterial changes in pulmonary veno-occlusive disease, mitral stenosis and fibrosing mediastinitis. Eur Respir J 15 (2000) 116-122
28. Jais X., Launay D., Yaici A., Le Pavec J., Tcherakian C., Sitbon O., et al. Management of lupus and mixed connective tissue disease-associated pulmonary arterial hypertension. Arthritis Rheum 58 (2008) 521-531
29. Sanchez O., Sitbon O., Jais X., Simonneau G., and Humbert M. Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension. Chest 130 (2006) 182-189
30. Montani D., Sitbon O., Jaïs X., Cabrol S., Simonneau G., and Humbert M. Traitement de l'hypertension artérielle pulmonaire. Presse Med 34 (2005) 1445-1455
31. Montani D, Jaïs X, Dorfmüller P, Simonneau G, Sitbon O, Humbert M. Goal-oriented therapy in pulmonary veno-occlusive disease: a word of caution. Eur Respir J 2009; 34:1204-6.
32. Montani D., Chaumais M.C., Savale L., Natali D., Price L.C., Jaïs X., et al. Phosphodiesterase type 5 inhibitors in pulmonary arterial hypertension. Adv Ther (2009) 10.1007/s12325-009-0064-z
33. Okumura H., Nagaya N., Kyotani S., Sakamaki F., Nakanishi N., Fukuhara S., et al. Effects of continuous IV prostacyclin in a patient with pulmonary veno-occlusive disease. Chest 122 (2002) 1096-1098
34. Davis L.L., deBoisblanc B.P., Glynn C.E., Ramirez C., and Summer W.R. Effect of prostacyclin on microvascular pressures in a patient with pulmonary veno-occlusive disease. Chest 108 (1995) 1754-1756
35. Hoeper M.M., Eschenbruch C., Zink-Wohlfart C., Schulz A., Markworth S., Pohl K., et al. Effects of inhaled nitric oxide and aerosolized iloprost in pulmonary veno-occlusive disease. Respir Med 93 (1999) 62-64
36. Kuroda T., Hirota H., Masaki M., Sugiyama S., Oshima Y., Terai K., et al. Sildenafil as adjunct therapy to high-dose epoprostenol in a patient with pulmonary veno-occlusive disease. Heart Lung Circ 15 (2006) 139-142
37. Barreto A.C., Franchi S.M., Castro C.R., and Lopes A.A. One-year follow-up of the effects of sildenafil on pulmonary arterial hypertension and veno-occlusive disease. Braz J Med Biol Res 38 (2005) 185-195
38. Almagro P., Julia J., Sanjaume M., González G., Casalots J., Heredia J.L., et al. Pulmonary capillary hemangiomatosis associated with primary pulmonary hypertension: report of 2 new cases and review of 35 cases from the literature. Medicine (Baltimore) 81 (2002) 417-424